{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-004619","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.417650+00:00","generated_at":"2026-05-31T23:45:46.151376+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Phio Pharmaceuticals implements 1-for-9 reverse stock split effective July 5, 2024","bullets":["Reverse split ratio set at 1-for-9; reduces outstanding shares from ~4.6M to ~0.5M.","Split effective 12:01 a.m. ET on July 5, 2024; trading symbol remains PHIO.","Adopted to meet Nasdaq minimum $1.00 bid price requirement for continued listing.","No fractional shares issued; cash payment in lieu for fractional holdings.","CUSIP changed to 71880W501; transfer agent Computershare managing exchange."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-004619","json":"https://secwatch.observer/filing/0001683168-24-004619.json","markdown":"https://secwatch.observer/filing/0001683168-24-004619.md","text":"https://secwatch.observer/filing/0001683168-24-004619.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824004619/0001683168-24-004619-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824004619/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:45:46.151376+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}